Has Dimitar Zlatev, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,145 in general payments to Dimitar Zlatev, MD across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dimitar Zlatev, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dimitar Zlatev, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dimitar Zlatev, MD

Urology · Reno, NVNPI 1841589132

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,010 of the $1,145 with a category attached, or 88.2%. 8 manufacturers reported payments, led by Johnson & Johnson at 32.0% of the total. That places this record below the midpoint for urology clinicians in NV, where the typical reported total is $2,990.

$1,145in general payments, 2019–2025

Across 18 payments — averaging $63.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$366
Sumitomo Pharma America, Inc.$259
Coloplast$193
Janssen Scientific Affairs, LLC$168
Procept Biorobotics Corporation$81
AstraZeneca$35
plus $43 from 2 others

What the payments were for

Food & beverage$1,01088%
Education$13512%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	8	$366
Sumitomo Pharma America, Inc.	2	$259
Coloplast	2	$193
Janssen Scientific Affairs, LLC	2	$168
Procept Biorobotics Corporation	1	$81
AstraZeneca	1	$35
Medline Industries LP	1	$22
Progenics Pharmaceuticals, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ORGOVYX$259
TITAN$125

How this compares

$1,145 in reported general payments places this provider in the 30th percentile of 63 urology providers in Nevada.

See all urology providers in Nevada →

Medicare billing

Part B allowed, 2024

$267,740

Medicare patients

487

Services billed

4,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	213	$2,873
Oxybutynin Chloride ErOxybutynin Chloride	34	$389
Finasteride	23	$194
Cefdinir	20	$187
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$82
Oxycodone Hcl	28	$75
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	14	$30

Paid to pharmacies, not to this prescriber.

Other urology in Reno

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →